4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-21-008655
Options or other derivatives
- Chief Clinical Dev. Officer acquired 27,213 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pano Arian · Chief Clinical Dev. Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-02 | Grant or award : show line 1 in the form Share Option | +23,325 | 23,325 | D |
| 2021-09-02 | Grant or award : show line 2 in the form Restricted Share Units | +3,888 | 3,888 | D |
Loading xslF345X03/edgar.xml…